Generic Drug Market in Japan 2010

Language:
English
Product Code No:
C52115930
Issued In:
2010/12
#of Pages:
187
Publication Cycle:
  
Format:
PDF
For More Info.:
 Table of Contents
Geographic Coverage:
Japan
Industry:

Price

300,000 yen ($2,778.55)
(excluding consumption tax)
600,000 yen ($5,557.10)
(excluding consumption tax)
900,000 yen ($8,335.65)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 107.97 yen , 2020/03/28 Japan)

Coverage: (Product/service)

Generic drug market

Research Target:

Manufacturers

Research Content:

Generic Drug Market in Japan 2010 is a comprehensive resource book on the current generic drug market in Japan. It provides you with a full picture of the market by covering market size, market share, industry restructuring trends, products on NHI drug price list, distribution structure, and company strategies. The original book is written in Japanese and published in September 2010, which has been developed by Yano Research Institute’s experienced life science market research team members. This time the content is condensed and compiled with use of more tables, graphs and charts into a Japanese and English bilingual format.
 
  • Aiming to achieving the target of 30% or more for market share on a volume basis in FY 2012, additional premium requirements for generic dispensing will be reviewed in FY 2020 revision of health insurance reimbursement. The use of generic drugs in the dispensing pharmacy market is expected to become active responding to the increase of demands.
  • The generic drug market has entered the growth stage but become more competitive with new entrants one after another. Generic manufacturers are forced to optimize their growth strategies looking ahead.
KEY FEATURES OF THE REPORT
■ The content of “Generic Drug Market 2010” published in September 2010 is summarized with use of tables, graphs and charts.
■ The report is compiled into a Japanese and English bilingual format for global business people.
■ Key points are described succinctly for changing generic drug market environments and market player trends in Japan.

TOC:

CHAPTER 1: MARKET ENVIRONMENTS
Overview
Market Conditions in United States and Europe
Market Environments of Generic Drugs -- History
Market Environments of Generic Drugs -- Dawn
Market Environments of Generic Drugs -- Introduction
Market Environments of Generic Drugs -- Growth
Governmental Measures to Achieve 30% Market Share for Generic Drugs
Market Environments of Generic Drugs
Market Size
Market Size Forecast 1
Market Size Forecast 2
Influential Factors in Market Size Forecast (FY 2010 to FY 2012) 1
Influential Factors in Market Size Forecast (FY 2010 to FY 2012) 2
 
CHAPTER 2: COMPANY TRENDS AND STRATEGIES
Market Players
Types of Market Players
Revenue Size
Market Share 1
Market Share 2
Market Share 3
Sales Ranking 1
Sales Ranking 2
Sales Ranking 3
Changes in Sales of Top 4 Companies
Growth Factors for Top 4 Companies
Growth Factor -- DPC Hospitals
Sales Value Targets of Top 4 Companies
Generic Drug Industry Restructuring
Restructuring Trends 1
Restructuring Trends 2
Restructuring Trends 3
Restructuring Trends 4
Restructuring of Dedicated Generic Manufacturers
Entries of Foreign Generic Manufacturers
Restructuring Trends of Foreign Generic Manufacturers 1
Restructuring Trends of Foreign Generic Manufacturers 2
Entries from Different Industries
Entry Patterns and Trends of Manufacturers from Different Industries
Entries of Brand Drug Manufacturers
Types of Brand Drug Manufacturers in Market
Generic Sales Value Targets of Brand Drug Manufacturers
Issues and Challenges in Generic Drug Business of Brand Drug Manufacturers
R&D Cost Trends
Capital Investment Trends
Changes in Number of Products on NHI Drug Price List 1
Changes in Number of Products on NHI Drug Price List 2
Company Ranking (Top 30) by Number of Dosages on NHI Drug Price List
Company Ranking (Top 50) by Number of Dosages on NHI Drug Price List
Company Ranking by Number of Dosages on NHI Drug Price List by Dosage Form
Distribution Structure -- Distribution Patterns
Distribution Structure -- Distribution Channels
Distribution Structure -- Direct Sales Channel
Distribution Structure -- Sales Company Channel
Distribution Structure -- Pharmaceutical Wholesaler Channel
Sales Force Structure -- Changes in Number of Medical Representatives
Sales Force Structure -- Number of Medical Representatives by Company
Differentiation Strategies -- Overview
Differentiation Strategies -- Dosage Forms
Differentiation Strategies -- Drug Categories 1
Differentiation Strategies -- Drug Categories 2
Differentiation Strategies -- Drug Categories 3
Differentiation Strategies -- Drug Categories 4
Differentiation Strategies -- Drug Categories 5
Differentiation Strategies -- Drug Categories 6 (Anti-cancer Generics)
Pricing Strategies 1
Pricing Strategies 2
Company and Industry Trends 1
Company and Industry Trends 2
 
CHAPTER 3: COMPANY PROFILES
Actavis Aska K.K.
Kyorin Rimedio Co., Ltd.
Kyowa Pharmaceutical Industry Co., Ltd.
Teva-Kowa Pharma Co., Ltd.
Zydus Pharma Japan Co., Ltd.
Sawai Pharmaceutical Co., Ltd.
Sandoz K.K.
Daiichi Sankyo Espha Co., Ltd.
Taiyo Yakuhin Co., Ltd.
Tanabe Seiyaku Hanbai Co., Ltd.
Towa Pharmaceutical Co., Ltd.
Nichi-Iko Pharmaceutical Co., Ltd.
Nissin Pharmaceutical Co., Ltd.
Nipro Pharma Corporation
Nippon Kayaku Co., Ltd.
Nippon Chemiphar Co., Ltd.
Nihon Generic Co. Ltd.
Pfizer Japan Inc.
Fuji Pharma Co., Ltd.
Fujifilm Pharma Co., Ltd.
Hospira Japan Co., Ltd.
Mylan Seiyaku Ltd.
Meiji Seika Kaisha, Ltd.

Price

written in English
300,000 yen ($2,778.55)
(excluding consumption tax)
600,000 yen ($5,557.10)
(excluding consumption tax)
900,000 yen ($8,335.65)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 107.97 yen , 2020/03/28 Japan)